OBALON THERAPEUTICS INC's ticker is and the CUSIP is 67424L209. A total of 17 filers reported holding OBALON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $161,000 | +847.1% | 57,161 | +388.2% | 0.00% | – |
| Q4 2020 | $17,000 | +70.0% | 11,709 | 0.0% | 0.00% | – |
| Q3 2020 | $10,000 | +25.0% | 11,709 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | 0.0% | 11,709 | -0.2% | 0.00% | – |
| Q1 2020 | $8,000 | -81.8% | 11,730 | -50.0% | 0.00% | – |
| Q4 2019 | $44,000 | +109.5% | 23,460 | +107.5% | 0.00% | – |
| Q3 2019 | $21,000 | – | 11,308 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 380,224 | $346,000 | 0.10% |
| ARMISTICE CAPITAL, LLC | 740,000 | $674,000 | 0.02% |
| Cerity Partners LLC | 155,000 | $141,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 33,000 | $30,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 40 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 332 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 11,709 | $10,000 | 0.00% |
| CITIGROUP INC | 500 | $0 | 0.00% |
| MORGAN STANLEY | 700,010 | $637,000 | 0.00% |